Lingotto Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472M | Buy |
28,156,918
+302,975
| +1% | +$5.08M | 10.03% | 3 |
|
|
2025
Q1 | $428M | Buy |
27,853,943
+661,555
| +2% | +$10.2M | 11.18% | 3 |
|
|
2024
Q4 | $599M | Buy |
27,192,388
+688,862
| +3% | +$15.2M | 16.08% | 2 |
|
|
2024
Q3 | $478M | Buy |
26,503,526
+40,926
| +0.2% | +$737K | 13.77% | 2 |
|
|
2024
Q2 | $430M | Buy |
26,462,600
+38,065
| +0.1% | +$619K | 14.45% | 2 |
|
|
2024
Q1 | $373M | Sell |
26,424,535
-8,033,121
| -23% | -$113M | 15.61% | 1 |
|
|
2023
Q4 | $360M | Buy |
34,457,656
+607,800
| +2% | +$6.35M | 17.32% | 1 |
|
|
2023
Q3 | $345M | Buy |
33,849,856
+9,636,595
| +40% | +$98.3M | 18.51% | 1 |
|
|
2023
Q2 | $182M | Buy |
24,213,261
+7,121,351
| +42% | +$53.6M | 11.78% | 2 |
|
|
2023
Q1 | $151M | Buy |
17,091,910
+2,083,521
| +14% | +$18.4M | 10.83% | 2 |
|
|
2022
Q4 | $93.9M | Buy |
15,008,389
+3,486,202
| +30% | +$21.8M | 7.05% | 9 |
|
|
2022
Q3 | $93M | Buy |
+11,522,187
| New | +$93M | 8.56% | 6 |
|
|
2022
Q1 | – | Sell |
-15,008,389
| Closed | -$93.9M | – | 20 |
|
|
2021
Q4 | $93.9M | Buy |
+15,008,389
| New | +$93.9M | 7.05% | 9 |
|